These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16868651)

  • 1. The renal type H+/peptide symporter PEPT2: structure-affinity relationships.
    Biegel A; Knütter I; Hartrodt B; Gebauer S; Theis S; Luckner P; Kottra G; Rastetter M; Zebisch K; Thondorf I; Daniel H; Neubert K; Brandsch M
    Amino Acids; 2006 Sep; 31(2):137-56. PubMed ID: 16868651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis.
    Biegel A; Gebauer S; Brandsch M; Neubert K; Thondorf I
    J Med Chem; 2006 Jul; 49(14):4286-96. PubMed ID: 16821788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
    Luckner P; Brandsch M
    Eur J Pharm Biopharm; 2005 Jan; 59(1):17-24. PubMed ID: 15567297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.
    Döring F; Martini C; Walter J; Daniel H
    J Membr Biol; 2002 Mar; 186(2):55-62. PubMed ID: 11944083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of beta-lactam antibiotics with H+/peptide cotransporters in rat renal brush-border membranes.
    Takahashi K; Nakamura N; Terada T; Okano T; Futami T; Saito H; Inui KI
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1037-42. PubMed ID: 9694966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
    Biegel A; Gebauer S; Hartrodt B; Brandsch M; Neubert K; Thondorf I
    J Med Chem; 2005 Jun; 48(13):4410-9. PubMed ID: 15974593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
    Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
    Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
    Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.
    Groneberg DA; Döring F; Theis S; Nickolaus M; Fischer A; Daniel H
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1172-9. PubMed ID: 11934684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
    Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
    Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.
    Fei YJ; Liu JC; Fujita T; Liang R; Ganapathy V; Leibach FH
    Biochem Biophys Res Commun; 1998 May; 246(1):39-44. PubMed ID: 9600064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice.
    Ocheltree SM; Shen H; Hu Y; Keep RF; Smith DE
    J Pharmacol Exp Ther; 2005 Oct; 315(1):240-7. PubMed ID: 15987832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.
    Groneberg DA; Fischer A; Chung KF; Daniel H
    Am J Respir Cell Mol Biol; 2004 Mar; 30(3):251-60. PubMed ID: 14969997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
    Döring F; Walter J; Will J; Föcking M; Boll M; Amasheh S; Clauss W; Daniel H
    J Clin Invest; 1998 Jun; 101(12):2761-7. PubMed ID: 9637710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid in vitro screening for delivery of peptide-derived peptidase inhibitors as potential drug candidates via epithelial peptide transporters.
    Foltz M; Meyer A; Theis S; Demuth HU; Daniel H
    J Pharmacol Exp Ther; 2004 Aug; 310(2):695-702. PubMed ID: 15051798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism induces expression of the peptide transporter PEPT2.
    Döring F; Schmitt R; Bernhardt WM; Klapper M; Bachmann S; Daniel H; Groneberg DA
    Biol Chem; 2005 Aug; 386(8):785-90. PubMed ID: 16201874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
    Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
    Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on renal peptide transporters.
    Daniel H; Rubio-Aliaga I
    Am J Physiol Renal Physiol; 2003 May; 284(5):F885-92. PubMed ID: 12676733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.
    Groneberg DA; Nickolaus M; Springer J; Döring F; Daniel H; Fischer A
    Am J Pathol; 2001 Feb; 158(2):707-14. PubMed ID: 11159208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice.
    Shen H; Ocheltree SM; Hu Y; Keep RF; Smith DE
    Drug Metab Dispos; 2007 Jul; 35(7):1209-16. PubMed ID: 17452417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.